Letrozole as Primary Medical Therapy for Locally Advanced and Large Operable Breast Cancer
- 1 April 2001
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 66 (3) , 191-199
- https://doi.org/10.1023/a:1010669403283
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancerAnnals of Oncology, 1998
- Tamoxifen for Breast Cancer PreventionExperimental Biology and Medicine, 1995
- Systemic Therapy in Breast CancerPharmacoEconomics, 1994
- Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatmentBritish Journal of Surgery, 1994
- in situ oestrone synthesis in normal breast and breast tumour tissues: Effect of treatment with 4‐hydroxyandrostenedioneInternational Journal of Cancer, 1989
- Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancerBritish Journal of Cancer, 1989
- Aromatase activity in normal breast and breast tumor tissues: In vivo and in vitro studiesSteroids, 1987
- Consistent definitions of tumor response.Journal of Clinical Oncology, 1986
- Breast carcinoma in the elderly patient: An assessment of operative risk, morbidity and mortalityThe American Journal of Surgery, 1980
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977